Compositions and methods for indirectly reducing incidence of fungal pathogen activity in plants

US10694751B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10694751-B2
Application numberUS-201916567597-A
CountryUS
Kind codeB2
Filing dateSep 11, 2019
Priority dateSep 13, 2018
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for indirectly reducing incidence of fungal pathogen infection in a plant are disclosed, wherein the fungal pathogen may be Botrytis, Macrophomina, Rhizoctonia, Sclerotinia, or Verticillium. The compositions comprise pasteurized microalgae cells in an amount effective to reduce incidence of the fungal pathogen in a plant compared to a substantially identical population of untreated plants. The composition treatment can include at least one microalgae such as Chlorella, Aurantiochytrium acetophilum HS399, Galdieria, Scenedesmus, Haematococcus, Isochrysis, Spirulina or any combination thereof. Where the composition comprises a combination of a first microalgae and a second microalgae, the composition may consist of a ratio of 25:75, 50:50: or 75:25.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of reducing incidence of fungal pathogen infection in a plant comprising administering to soil in the immediate vicinity of a plant, seedling, or seed an amount of a microalgae composition that is effective to reduce incidence of the fungal pathogen in the plant compared to a substantially identical population of untreated plants, wherein the microalgae composition comprises at least one of pasteurized Chlorella , pasteurized Aurantiochytrium acetophilum HS399 cells, pasteurized Galdieria cells, pasteurized Scenedesmus cells, pasteurized Haematococcus cells, pasteurized Isochrysis cells, and pasteurized Spirulina cells, and wherein the fungal pathogen is one of Botrytis, Macrophomina, Rhizoctonia, Sclerotinia , and Verticillium. 2. The method claim 1 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Aurantiochytrium acetophilum HS399 cells in a ratio of 25:75. 3. The method of claim 1 wherein the microalgae composition is a liquid and is administered at a rate in the range of 0.25-1.0 gallon/acre. 4. The method of claim 3 wherein the microalgae composition comprises between 100 g-400 g per acre of at least one of solid pasteurized Chlorella cells and solid pasteurized Aurantiochytrium acetophilum HS399 cells. 5. The method of claim 1 wherein the microalgae composition is a liquid and is administered at a rate in the range of 0.5% v/v-5.0% v/v. 6. The method of claim 5 wherein the microalgae composition comprises between 2 g-20 g solid microalgae cells/gallon. 7. The method of claim 1 wherein the microalgae composition comprises pasteurized Aurantiochytrium acetophilum HS399 cells and the pasteurized Aurantiochytrium acetophilum HS399 cells comprise approximately 60% lipid. 8. The method of claim 1 wherein the microalgae composition comprises pasteurized Aurantiochytrium acetophilum HS399 cells and the pasteurized Aurantiochytrium acetophilum HS399 cells comprise approximately 45% lipid. 9. The method of claim 1 wherein the microalgae composition comprises pasteurized Aurantiochytrium acetophilum HS399 cells and the pasteurized Aurantiochytrium acetophilum HS399 cells comprise less than 40% lipid. 10. The method of claim 1 wherein microalgae composition comprises pasteurized Aurantiochytrium acetophilum HS399 cells that have been subjected to an extraction process to remove oils from the pasteurized Aurantiochytrium acetophilum HS399 cells. 11. The method of claim 1 wherein the microalgae composition comprises pasteurized Haematococcus cells that have been subjected to an extraction process to remove oils from the pasteurized Haematococcus cells. 12. The method of claim 1 wherein the microalgae composition comprises pasteurized Galdieria cells. 13. The method of claim 1 wherein the microalgae composition comprises pasteurized Scenedesmus cells. 14. The method of claim 1 wherein the microalgae composition comprises pasteurized Haematococcus cells. 15. The method claim 1 wherein the microalgae composition comprises pasteurized Isochrysis cells. 16. The method of claim 1 wherein the microalgae composition comprises pasteurized Spirulina cells. 17. A method of reducing incidence of fungal pathogen infection in a plant comprising administering to soil in the immediate vicinity of a plant, seedling, or seed an amount of a microalgae composition that is effective to reduce incidence of the fungal pathogen in the plant compared to a substantially identical population of untreated plants, wherein the microalgae composition comprises at least one of pasteurized Chlorella , pasteurized Aurantiochytrium cells, pasteurized Galdieria cells, pasteurized Scenedesmus cells, pasteurized Haematococcus cells, pasteurized Isochrysis cells, and pasteurized Spirulina cells, and wherein the fungal pathogen is one of Botrytis, Macrophomina, Rhizoctonia, Sclerotinia , and Verticillium. 18. The method of claim 17 wherein the microalgae composition is a liquid and is administered at a rate in the range of 0.25-1.0 gallon/acre. 19. The method of claim 17 wherein the microalgae composition is a liquid and is administered at a rate in the range of 0.5% v/v-5.0% v/v. 20. The method of claim 17 wherein the microalgae composition comprises between 2 g-20 g solid microalgae cells/gallon. 21. A method of reducing incidence of fungal pathogen infection in a plant comprising administering to soil in the immediate vicinity of a plant, seedling, or seed an amount of a microalgae composition that is effective to reduce incidence of the fungal pathogen in the plant compared to a substantially identical population of untreated plants, wherein the microalgae composition comprises pasteurized Chlorella and at least one of pasteurized Aurantiochytrium cells, pasteurized Galdieria cells, pasteurized Scenedesmus cells, pasteurized Haematococcus cells, pasteurized Isochrysis cells, and pasteurized Spirulina cells, and wherein the fungal pathogen is one of Botrytis, Macrophomina, Rhizoctonia, Sclerotinia , and Verticillium. 22. The method of claim 21 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Galdieria cells. 23. The method of claim 21 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Scenedesmus cells. 24. The method of claim 21 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Haematococcus cells. 25. The method claim 21 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Isochrysis cells. 26. The method of claim 21 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Spirulina cells. 27. The method of claim 21 wherein the microalgae composition comprises pasteurized Chlorella cells and pasteurized Aurantiochytrium cells. 28. The method of claim 27 wherein the pasteurized Aurantiochytrium cells are pasteurized Aurantiochytrium acetophilum HS399 cells.

Assignees

Inventors

Classifications

  • A01N63/30Primary

    Microbial fungi; Substances produced thereby or obtained therefrom · CPC title

  • Algae · CPC title

  • containing liquids as carriers, diluents or solvents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10694751B2 cover?
Compositions and methods for indirectly reducing incidence of fungal pathogen infection in a plant are disclosed, wherein the fungal pathogen may be Botrytis, Macrophomina, Rhizoctonia, Sclerotinia, or Verticillium. The compositions comprise pasteurized microalgae cells in an amount effective to reduce incidence of the fungal pathogen in a plant compared to a substantially identical population …
Who is the assignee on this patent?
Heliae Dev Llc
What technology area does this patent fall under?
Primary CPC classification A01N63/30. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).